Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
01 1Malladi Drugs & Pharmaceuticals Limited
02 1Patheon API Manufacturing, Inc.
01 1METARAMINOL BITARTRATE
02 1Metaraminol Bitartrate
01 1India
02 1U.S.A
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
NDC Package Code : 57218-750
Start Marketing Date : 2017-01-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64274-9001
Start Marketing Date : 2021-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Metaraminol Bitartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metaraminol Bitartrate, including repackagers and relabelers. The FDA regulates Metaraminol Bitartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metaraminol Bitartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metaraminol Bitartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metaraminol Bitartrate supplier is an individual or a company that provides Metaraminol Bitartrate active pharmaceutical ingredient (API) or Metaraminol Bitartrate finished formulations upon request. The Metaraminol Bitartrate suppliers may include Metaraminol Bitartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Metaraminol Bitartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metaraminol Bitartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metaraminol Bitartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metaraminol Bitartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metaraminol Bitartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metaraminol Bitartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metaraminol Bitartrate suppliers with NDC on PharmaCompass.
We have 2 companies offering Metaraminol Bitartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
